The Devil is in the (Data) Detail

Post-COVID healthcare delivery stress test to determine ability of U.S. system to sustain change.
By Katie Oberkircher Posted on October 6, 2020

Although the exact impact is unclear, the first moments of clarity can be found in the financial data, according to Third Horizon Strategies. The healthcare consulting firm teamed up with The Council and other national medical, care delivery, and insurance trade associations to uncover the longer-term effects of COVID-19 and the recession on the economics of the healthcare delivery system.

Dubbed the Post-Covid Delivery System Stress Test, this analysis measures the ability of the U.S. healthcare system to sustain a rapid shift in demand while maintaining the same rate of supply. Through a data-driven lens, this stress test considers variables like the nosedive in employment and how payments will shift if enrollment in public and private insurance plans change. The results will provide strategic and policy focus in 2021, but they will also allow certain stakeholders to be problem solvers. Brokers and consultants, medical professionals, financial analysts, insurance companies and telemedicine providers will be (virtually) shoulder to shoulder as they consider state and federal policy solutions and how to mitigate the financial stress of this once-in-a-generation pandemic.

Be on the lookout for the full study coming late 2020.

Katie Oberkircher Director, Market Intelligence & Insights Read More

More in Health+Benefits

Evaluating the Data on Digital Health
Health+Benefits Evaluating the Data on Digital Health
Q&A with Adam Cohen, MD, Assistant Professor of Neurology, Johns Hopkins Medicin...
Identifying the (Benefits) Gaps
Health+Benefits Identifying the (Benefits) Gaps
Three steps employers can take to move toward an inclusive culture
Do Bipartisan Healthcare Cost Solutions Exist?
Health+Benefits Do Bipartisan Healthcare Cost Solutions Exist?
A D.C. insider’s perspective on the chances of major drug pricing and ACA refo...
David Axelrod
Health+Benefits David Axelrod
On the future of the ACA, prescription drugs, pollsters, and...
The Compounding Business
Health+Benefits The Compounding Business
Q&A with Tara Thompson, Pharmacist and Vice President of Cli...